What is uvbiotek?
UVBioTek is a recognized leader in the field of phototherapy, specializing in advanced light medicine solutions for a spectrum of dermatological and aesthetic concerns. The company offers a comprehensive suite of products, encompassing both home-use and clinical systems, alongside pioneering LED light therapy innovations. Catering to a dual market of residential consumers and healthcare professionals, UVBioTek provides dedicated online portals for patients and physicians, facilitating seamless access to their therapeutic offerings. With a legacy spanning 25 years, UVBioTek is dedicated to advancing effective treatments for chronic skin conditions such as psoriasis, vitiligo, and eczema, solidifying its reputation for innovation and efficacy in light-based medicine.
How much funding has uvbiotek raised?
uvbiotek has raised a total of $166K across 1 funding round:
Debt
$166K
Debt (2021): $166K with participation from PPP
Key Investors in uvbiotek
PPP
Public-Private Partnership
What's next for uvbiotek?
The substantial capital infusion, particularly the recent strategic investment, positions UVBioTek for accelerated growth and market penetration. This funding is expected to fuel further research and development into novel phototherapy applications, enhance manufacturing capabilities, and expand its commercial reach into new geographical markets. The company's focus on addressing significant unmet needs in skin disorder treatment, coupled with its established track record, suggests a strategic trajectory aimed at solidifying its leadership in the global phototherapy sector. Future developments may include strategic partnerships and the introduction of next-generation devices.
See full uvbiotek company page
